glp-1 weight loss timeline Clinic in Cape Girardeau, MO Curious what to expect on
Description
Heres what you get with us and what you wont find anywhere else
GLP-1 receptor agonist use is associated with increased risk of osteoporosis, gout, and osteomalacia in adults with type 2 diabetes and obesity
Our model emphasizes precision and personalization: we support genetic testing to contextualize metabolic predispositions, facilitate provider consultations, and work collaboratively with your clinician to optimize dosing and formulation
Ask the Gala provider during your consultation whether FDA-approved alternatives exist for your specific regimen
